Press release
Metastatic-Liver-Cancer Pipeline Insight| Key Companies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics Inc, RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeu
Metastatic-Liver-Cancer Pipeline
Key Takeaways from the Metastatic-Liver-Cancer Pipeline Report
• DelveInsight's Metastatic-Liver-Cancer pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Metastatic-Liver-Cancer treatment.
• The leading Metastatic-Liver-Cancer Companies includes Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
• Promising Metastatic-Liver-Cancer Pipeline Therapies includes Adecatumumab, FOLFOX 4, EMD 525797, AV-299, AZD2171, Talimogene Laherparepvec, Atezolizumab, STP705, and others.
• The Metastatic-Liver-Cancer Companies and academics are working to assess challenges and seek opportunities that could influence Metastatic-Liver-Cancer R&D. The Metastatic-Liver-Cancer pipeline therapies under development are focused on novel approaches to treat/improve Metastatic-Liver-Cancer.
To explore more information on the latest breakthroughs in the Metastatic-Liver-Cancer Pipeline treatment landscape of the report, click here @ Metastatic-Liver-Cancer Pipeline Outlook- https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Metastatic-Liver-Cancer Overview
The liver is a common site for metastases from many cancer types. Cancers that spread to the liver most often are colorectal cancer as well as with breast, esophageal, stomach, pancreatic, lung, kidney and melanoma skin cancers. Cancers spread to the liver because the liver filters most of the blood from the rest of the body, and when cancer cells break away from a primary cancer, they often enter and travel through the bloodstream. Sometimes the discovery of metastatic liver cancer is the first indication that a person has cancer.
Metastatic-Liver-Cancer Emerging Drugs Profile
• exoASO STAT6: Codiak BioSciences
exoASO™-STAT6 is an exosome therapeutic candidate engineered using our engEx™ Platform to overexpress Codiak's novel protein scaffold, PTGFRN, to selectively target uptake in M2 polarized tumor-associated macrophages. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
• STP 705: Sirnaomics
STP705, is a dual TGF-ß1/COX-2 inhibitor. TGF-ß1 and COX-2 are well-validated gatekeeper targets for oncology and fibrosis disease drug development. STP705 leverages our locally administered PNP formulation for direct administration to diseased tissue. STP705 has received U.S. orphan drug designation for the treatment of certain hepatocellular carcinomas and liver fibrosis, including: primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
• ONCR 177: Oncorus
ONCR-177, our lead product candidate, is an intratumorally administered Herpes Simplex Virus (HSV) viral immunotherapy for the treatment of multiple solid tumor cancers. ONCR-177 fights tumors through multiple mechanisms, including inherent oncolytic activity, immune stimulation elicited by viral infection and the expression of five transgenes (IL-12, CCL4, FLT3LG, anti-PD-1 and anti-CTLA-4). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.
For further information, refer to the detailed Metastatic-Liver-Cancer Unmet Needs, Metastatic-Liver-Cancer Market Drivers, and Market Barriers, click here for Metastatic-Liver-Cancer Ongoing Clinical Trial Analysis- https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Metastatic-Liver-Cancer Pipeline Therapeutics Assessment
There are approx. 20+ key companies which are developing the therapies for Metastatic-Liver-Cancer. The companies which have their Metastatic-Liver-Cancer drug candidates in the most advanced stage, i.e. phase I include, Oncorus.
Metastatic-Liver-Cancer Phases
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Request a sample and discover the recent advances in Metastatic-Liver-Cancer Ongoing Clinical Trial Analysis and Medications, click here @ Metastatic-Liver-Cancer Treatment Landscape- https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Metastatic-Liver-Cancer Pipeline Insight Report
• Coverage- Global
• Metastatic-Liver-CancerCompanies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
• Metastatic-Liver-Cancer Pipeline Therapies- Adecatumumab, FOLFOX 4, EMD 525797, AV-299, AZD2171, Talimogene Laherparepvec, Atezolizumab, STP705, and others
• Metastatic-Liver-Cancer Segmentation: Product Type, Molecule Type, Mechanism of Action, Route of Administration
Dive deep into rich insights for drugs for Mantle Cell Lymphoma Market Drivers and Mantle Cell Lymphoma Market Barriers, click here @ Mantle Cell Lymphoma Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Metastatic-Liver-Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Metastatic-Liver-Cancer- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Drug name :Company Name
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Drug name :Company Name
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. ONCR 177: Oncorus
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name :Company Name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Metastatic-Liver-Cancer Key Companies
21. Metastatic-Liver-Cancer Key Products
22. Metastatic-Liver-Cancer- Unmet Needs
23. Metastatic-Liver-Cancer- Market Drivers and Barriers
24. Metastatic-Liver-Cancer- Future Perspectives and Conclusion
25. Metastatic-Liver-Cancer Analyst Views
26. Metastatic-Liver-Cancer Key Companies
27. Appendix
Got Queries? Find out the related information on Metastatic-Liver-Cancer Mergers and acquisitions, Metastatic-Liver-Cancer Licensing activities @ Metastatic-Liver-Cancer Emerging Drugs, and Recent Trends- https://www.delveinsight.com/sample-request/metastatic-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV 89107
Country: United States
Website: https://www.delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic-Liver-Cancer Pipeline Insight| Key Companies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics Inc, RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeu here
News-ID: 3063855 • Views: …
More Releases from DelveInsight Business Research
Autosomal Dominant Optic Atrophy Market Set for Robust Growth Through 2034, Driv …
The autosomal dominant optic atrophy treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and R&D in precision medicine from key pharmaceutical players, including PYC Therapeutics and Stoke Therapeutics, among others.
DelveInsight's "Autosomal Dominant Optic Atrophy - Market Insight, Epidemiology And Market Forecast - 2034" report delivers an in-depth understanding of the ADOA treatment market, historical and forecasted epidemiology, as well as market trends across the US,…
Severe Asthma Market Set for Robust Growth Through 2034, Driven by Breakthrough …
The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key pharmaceutical players, including AstraZeneca, GlaxoSmithKline, Amgen, Teva Pharmaceutical Industries, Novartis, Sanofi, Regeneron Pharmaceutical, Boehringer Ingelheim Pharmaceuticals, Kyorin Pharmaceutical, Pfizer, Chiesi Farmaceutici, AB Science, Avalo Therapeutics, and Theravance Biopharma, among others.
DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034" report delivers a comprehensive understanding of the severe asthma…
Systemic Lupus Erythematosus Pipeline Heats Up as 120+ Companies Advance Cutting …
The systemic lupus erythematosus (SLE) treatment pipeline is experiencing unprecedented expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Biogen, Idorsia Pharmaceuticals, AbbVie, BioSenic, Roche, Novartis, Allogene Therapeutics, Adicet Bio, and numerous other leading companies advancing innovative treatments through robust clinical development programs.
DelveInsight's "Systemic Lupus Erythematosus Pipeline Insight, 2025" report delivers comprehensive insights about 120+ companies and 140+ pipeline drugs currently in the…
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
More Releases for Pipeline
Refined Petroleum Products Pipeline Transportation Market: Insights, Trends and …
Refined Petroleum Products Pipeline Transportation Market Overview:
Refined petroleum products pipeline transportation industry comprises establishments primarily engaged in the pipeline transportation of refined petroleum products.. The global Refined Petroleum Products Pipeline Transportation Report contents include Size in value for the Refined Petroleum Products Pipeline Transportation market, drivers, trends and challenges, by end user, and growth rate during the forecast period, 2023-2030. Historical figures are also provided.
Get Sample Report @ https://reportsinsights.com/sample/671217
Key Competitors…
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Presbyopia Pipeline Insight Report
• Presbyopia Pipeline report offers a comprehensive…
Scleroderma Pipeline | 20+ Key Players & 22+ Pipeline Drugs | DelveInsight
DelveInsight's, "Scleroderma Pipeline Insight, 2022," report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Scleroderma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Scleroderma Pipeline Insight Report
• DelveInsight's analysis depicts a robust…
Malaria Pipeline Landscape Analysis: 15+ Key Players & 20+ Pipeline Drugs
DelveInsight's, "Malaria Pipeline Insight, 2022," report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Malaria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
In the Malaria Pipeline report, detailed description of the drug is given which…
Refined Petroleum Products Pipeline Transportation Market is Booming with Strong …
Refined Petroleum Products Pipeline Transportation Market Report research report is a wide-ranging analysis and Impact of COVID19 in the global market and the in-detail information with segmentation has been added in this intelligence report. In this report a comprehensive analysis of current global Global Refined Petroleum Products Pipeline Transportation Market market in terms of demand and supply environment is provided, as well as price trend currently and in the next…
Refined Petroleum Products Pipeline Transportation Global Market 2018: Key Playe …
Refined petroleum products pipeline transportation industry comprises establishments primarily engaged in the pipeline transportation of refined petroleum products.
Introduction of new and advanced technologies in the industry is highly increasing the demand of refined petroleum products pipeline transportation market. Several countries has begun with the usage of drones and advanced surveillance systems for pipeline monitoringand also to protect oil pipelines from any disrupt acts. With these new robotics and IoT solutions…
